Published by
@ShahidNShah
@ShahidNShah
BioSymetrics accelerates drug discovery with AI, precision medicine, and strategic partnerships.
BioSymetrics pioneers AI-driven target discovery and precision medicine. By bridging human and model system data, utilizing machine learning, and validating new targets in vivo, they accelerate drug discovery with confidence. Collaborating with pharmaceutical giants, hospitals, and genomics leaders, BioSymetrics accesses a vast dataset, propelling research in neurological, cardiometabolic, and rare diseases, particularly epilepsy.
Connecting innovation decision makers to authoritative information, institutions, people and insights.
Medigy accurately delivers healthcare and technology information, news and insight from around the world.
Medigy surfaces the world's best crowdsourced health tech offerings with social interactions and peer reviews.
© 2024 Netspective Foundation, Inc. All Rights Reserved.
Built on Nov 15, 2024 at 12:42pm